IGC Pharma, Inc. (IGC)
(Delayed Data from AMEX)
$0.40 USD
-0.02 (-4.50%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $0.39 -0.01 (-2.28%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, IGC Pharma, Inc. has a market cap of $38.43M, which represents its share price of $0.42 multiplied by its outstanding shares number of 91.96M. As a small-cap company, IGC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IGC 0.40 -0.02(-4.50%)
Will IGC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IGC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IGC
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
IGC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates
IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates
Other News for IGC
MACD Bullish Signal Line Cross appears for IGC after 1.44% move
IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders
20 Day Moving Average Support appears for IGC after 2.69% move
Is IGC primed for upward momentum? Crossed Above 20 Day Moving Average shows up after rising 1.95%
IGC's Latest Discovery in Alzheimer's Treatment Shows Promise